96 related articles for article (PubMed ID: 2544049)
1. [Interleukin-1-like factor from human B-lymphocytes transformed by the Epstein-Barr virus].
Kotov AIu; Simbirtsev AS; Perumov ND; Ketlinskiĭ SA
Tsitologiia; 1989 Feb; 31(2):226-33. PubMed ID: 2544049
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line.
Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W
Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138
[TBL] [Abstract][Full Text] [Related]
3. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.
Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K
J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079
[TBL] [Abstract][Full Text] [Related]
4. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
Matsushima K; Akahoshi T; Yamada M; Furutani Y; Oppenheim JJ
J Immunol; 1986 Jun; 136(12):4496-502. PubMed ID: 3011895
[TBL] [Abstract][Full Text] [Related]
5. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
[TBL] [Abstract][Full Text] [Related]
6. Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.
Scala G; Morrone G; Tamburrini M; Alfinito F; Pastore CI; D'Alessio G; Venuta S
J Immunol; 1987 Apr; 138(8):2527-34. PubMed ID: 2435800
[TBL] [Abstract][Full Text] [Related]
7. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
8. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
Stuart AD; Stewart JP; Arrand JR; Mackett M
Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
[TBL] [Abstract][Full Text] [Related]
11. Expression of the IL-6 gene induces differentiation of a human monoclonal EBV-transformed B cell line.
Jochems GJ; Bende RJ; Klein MR; Zeijlemaker WP; van Lier RA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):124-33. PubMed ID: 8395233
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1.
Valentine M; Lotz M; Dinarello CA; Carson DA; Vaughan JH
Lymphokine Res; 1986; 5(3):173-83. PubMed ID: 3018386
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
15. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a B cell-derived growth-enhancing factor produced by a human B cell line established from a patient with rheumatoid arthritis.
Kang H; Koyasu S; Takei M; Tomura K; Karasaki M; Yahara I; Sawada S
J Immunol; 1987 Aug; 139(4):1154-60. PubMed ID: 3497197
[TBL] [Abstract][Full Text] [Related]
17. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
19. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
[TBL] [Abstract][Full Text] [Related]
20. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
Woodford NL; Call DR; Remick DG; Rochford R
Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
